Refractory Shock in Pediatric Emergency Departments: Challenges and Innovations in Early Escalation: A Narrative Review

Abstract

Refractory shock in children carries persistently high mortality, particularly in low-resource settings. It occurs when circulatory failure persists despite adequate fluid resuscitation and vasoactive medications. This review summarizes pathophysiology, recognition, and escalation strategies for pediatric refractory shock, emphasizing early identification in the emergency department. It examines evidence for fluid management, vasoactive therapy, and point-of-care ultrasound in optimizing decision-making, along with second-line options such as corticosteroids, vasopressin, and milrinone. Special attention is given to resource-constrained settings, describing evidence-based adaptations including conservative fluid strategies from the FEAST trial, simplified algorithms, simulation-based training, and telemedicine. Improving outcomes requires rapid recognition, precise hemodynamic phenotyping, and timely evidence-based interventions.

Introduction

Pediatric shock is a life-threatening condition characterized by inadequate tissue perfusion and oxygen delivery, leading to rapid cellular injury and potential organ failure. The main types include septic shock (often triggered by severe infection), cardiogenic shock (resulting from cardiac pump failure), hypovolemic shock (due to significant fluid or blood loss), distributive shock (eg, anaphylaxis), and obstructive shock (eg, tamponade). While their underlying mechanisms differ, all require swift recognition and intervention to prevent irreversible damage ¹

Refractory shock is defined as persistent hypotension and signs of poor perfusion despite adequate fluid resuscitation (40-60 ml/kg) and appropriate initiation of vasoactive support, as outlined by the Pediatric Advanced Life Support (PALS) guidelines and refined by the Surviving Sepsis Campaign (SSC). This definition emphasizes the persistence of shock after correcting reversible factors and highlights the necessity of advanced hemodynamic assessment over simplistic “cold” versus “warm” clinical classification^2,3

The impact of early recognition in the emergency department (ED) cannot be overstated. Delays in intervention are consistently associated with increased mortality and organ dysfunction. ⁴ Implementing structured protocols, including sepsis screening tools and time-sensitive intervention bundles, has been shown to significantly shorten shock reversal time and reduce in-hospital mortality. ⁵ Adherence to evidence-based guidelines during the first “golden hour” of presentation is closely linked to improved survival. ⁶

Case Vignette: Impact of Delayed Care

A 7-year-old boy presented to a rural ED with fever, lethargy, and decreased urine output. Initially misdiagnosed with a viral illness, his resuscitation and antibiotics were delayed. Within hours, he developed fluid-refractory cold septic shock with myocardial dysfunction, requiring high-dose vasoactive support, prolonged mechanical ventilation, and intensive care. This case underscores the dire consequences of missed early warning signs, where delayed escalation converted a potentially reversible condition into a protracted, resource-intensive crisis with significant morbidity. ³

This review examines the epidemiology, pathophysiology, and diagnostic strategies for refractory pediatric shock, explores current and emerging management approaches, and proposes practical, resource-conscious interventions to improve outcomes in diverse ED settings.

Search Strategy and Study Selection

databases searched (PubMed, Scopus, Google Scholar), timeframe (2010-2025), search terms (“pediatric refractory shock,” “septic shock,” “POCUS,” “vasoactive agents,” “resource-limited settings”), and inclusion criteria (peer-reviewed articles, guidelines, RCTs, observational studies, systematic reviews).

Pathophysiology and Classification of Shock

Shock is a pathological state of global tissue hypoperfusion where oxygen delivery (DO₂) is insufficient to meet metabolic demands, forcing a shift to anaerobic metabolism and lactate accumulation. Understanding shock requires a firm grasp of oxygen transport physiology. ⁷

Oxygen Delivery and Consumption

• Oxygen Delivery (DO₂): DO₂ = Cardiac Output (CO) × Arterial Oxygen Content (CaO₂)

• ○ CaO₂ = (Hb × 1.34 × SaO₂) + (PaO₂ × 0.003). Hemoglobin concentration and saturation are the primary determinants.^8-10

Oxygen Consumption (VO₂): VO₂ = (CaO₂− CmvO₂) × CO. Reflects metabolic demand at the tissue level. ¹¹

Oxygen Extraction Ratio (O₂ER): O₂ER = (CaO₂−CvO₂) / CaO₂. This ratio increases during compensated shock to maintain VO₂ until a critical point is reached, beyond which anaerobic metabolism predominates. ¹² An O₂ER >50% signals approaching decompensation. ⁹ See Figure 1.

Figure 1.

Relationship between DO₂ and VO₂ with associated markers of tissue oxygenation.

It captures the supply-dependent versus supply-independent phases, and the changes in ScvO₂, lactate, and oxygen extraction shown in the graph.

Types of Shock

Identifying the type of shock is a cornerstone of effective treatment.

• a. Hypovolemic shock: Results from loss of circulating volume (hemorrhagic or non-hemorrhagic). Children present with tachycardia, delayed capillary refill, weak pulses, and cool extremities. Pitfalls include relying solely on blood pressure (a late sign) or underestimating ongoing losses. Management centers on rapid, controlled isotonic fluid resuscitation.^13,14

• b. Cardiogenic shock: Arises from impaired myocardial contractility (eg, myocarditis, congenital heart disease). Features include tachycardia, respiratory distress, hepatomegaly, and cool extremities. A common error is administering large fluid boluses for misinterpreted tachycardia, risking pulmonary edema. Treatment emphasizes inotropes and cautious fluid management.^15,16

• c. Distributive shock: Caused by abnormal vascular tone and vasodilation (eg, anaphylaxis, spinal shock). Children may have warm, flushed skin early on; spinal shock may present with hypotension without tachycardia. Pitfalls include delayed recognition of anaphylaxis and postponing epinephrine/vasopressors. Management requires trigger removal, epinephrine for anaphylaxis, and vasopressors.^17,18

• d. Septic shock: A form of distributive shock triggered by an infection-induced inflammatory cascade. In children, “cold shock” (low CO, high systemic vascular resistance [SVR]) is most common, with tachycardia, mottled cool skin, and delayed capillary refill. “Warm shock” (high CO, low SVR) is less common and features bounding pulses and flash capillary refill. A key challenge is distinguishing phenotypes to guide appropriate vasoactive therapy^19-21 (See Table 1).

• e. Obstructive shock: Occurs due to extracardiac mechanical obstruction of blood flow (eg, tension pneumothorax, cardiac tamponade). Presents with signs of shock plus specific features like distended neck veins or muffled heart sounds. It is often misdiagnosed as hypovolemic or cardiogenic shock. Management requires immediate relief of the obstruction.^22,23

Table 1.

Key Clinical Differences Between Warm and Cold Shock.

Feature	Cold shock	Warm shock
Hemodynamic profile	Low cardiac output (CO), high systemic vascular resistance (SVR)	High cardiac output (CO), low systemic vascular resistance (SVR)
Skin temperature	Cool extremities	Warm, flushed extremities
Capillary refill time	Prolonged (>2 seconds)	Flash or brisk (<1 second)
Pulse quality	Weak, thready pulses	Bounding pulses
Blood pressure	Narrow pulse pressure	Wide pulse pressure
Common phenotype	More common in children with septic shock	Less common in children; seen in late or distributive shock
Management focus	Improve contractility and perfusion (e.g., epinephrine)	Restore vascular tone (e.g., norepinephrine)

Initial Management and Escalation Triggers

Fluid Resuscitation: A Context-Dependent Paradigm

Fluid management strategies must be tailored to the healthcare setting and patient phenotype, as evidence supports different approaches. ²⁴

• High-income countries (HICs): SSC/ACCM-PALS guidelines recommend aggressive isotonic crystalloid boluses (10-20 ml/kg, repeated to 40-60 ml/kg in the first hour if no signs of overload), with advanced monitoring.^25,26

• Low- and middle-income countries (LMICs): The landmark FEAST trial demonstrated that fluid boluses (saline or albumin) increased 48-hour mortality by 3% absolute risk in African children without access to intensive care unit (ICU) care. In the subgroup meeting strict World Health Organization (WHO) shock criteria, mortality was 48% in the bolus group versus 20% in controls. This has prompted a shift toward conservative boluses (10-20 ml/kg over 30-60 minutes) with vigilant reassessment for overload in LMICs^27,28 (See Table 2). Notably, the optimal fluid strategy remains controversial. While SSC/ACCM-PALS guidelines advocate for aggressive resuscitation, the FEAST trial demonstrated harm with boluses in African children lacking ICU access, prompting a paradigm shift in resource-limited settings. This discordance highlights the need for context-specific protocols rather than a universal approach. ²⁸

Table 2.

Fluid Resuscitation Guidelines: HIC Versus LMIC.

Aspect	SSC & ACCM-PALS (HIC)	WHO ETAT + (LMIC)
Initial bolus	10-20, up to 40-60 ml/kg	10-20 ml/kg, cautious
Rationale	Improves perfusion, reduces mortality	FEAST trial: bolus increased mortality without ICU support

First-Line Vasoactive Agents: Epinephrine versus Dopamine

Overwhelming evidence supports epinephrine as the superior first-line agent for fluid-refractory cold septic shock.

• Ramaswamy et al & Ventura et al : Randomized controlled trials demonstrated epinephrine was significantly more effective at shock reversal (41% vs 13%) and resulted in lower 28-day mortality (7% vs 20.6%) compared to dopamine.^29,30

• Loomba et al Meta-Analysis: A systematic review of 397 patients confirmed lower mortality with epinephrine, reinforcing its superiority and better safety profile ³¹ (See Table 3). Despite meta-analytic evidence favoring epinephrine, practice variability persists due to factors such as regional drug availability, clinician familiarity, cost, and the absence of epinephrine in some formularies in low-resource settings. Additionally, dopamine remains in use for certain phenotypes or when epinephrine is not immediately accessible.

Table 3.

Epinephrine Versus Dopamine in Pediatric Shock.^29-31.

Study	Finding	Limitations/context
Ramaswamy et al. 29	Superior shock reversal (41% vs 13%)	RCT conducted in ICU; generalizability to ED unclear
Ventura et al. 30	Lower 28-day mortality (7% vs 20.6%)	Single-center study; need for multicenter validation
Loomba et al. 31 (meta-analysis)	Lower mortality with epinephrine	Most studies from high-resource settings; dopamine remains WHO essential medicine in some LMICs

Early Signs of Refractory Shock and Escalation Triggers

Hypotension is a late sign; clinical diagnosis is paramount. ³²

• Clinical signs of refractory shock: Prolonged capillary refill time (CRT) >2 seconds (cold shock), flash CRT or bounding pulses (warm shock), tachypnea, altered mental status, decreased urine output (<1 ml/kg/h), or signs of fluid overload (rales, hepatomegaly).^32,33

• Laboratory findings: Lactate >2 mmol/l indicates hypoperfusion. Lactate >4 mmol/l after fluid bolus signals high risk of multiple organ dysfunction syndrome (MODS) and necessitates immediate vasoactive support. Metabolic acidosis guides fluid and inotropic therapy.^34,35

• Prognostic scores: The pediatric Sequential Organ Failure Assessment (pSOFA) and Pediatric Logistic Organ Dysfunction-2 (PELOD-2) scores help stratify severity and predict mortality risk, guiding intervention intensity.^36,37

• Immediate actions: Clinical signs should trigger phenotypically guided action: start epinephrine for cold shock, norepinephrine for warm shock, and initiate vasoactive agents for persistent hyperlactatemia (Table 4).

Table 4.

Escalation Triggers and Immediate Actions.

Sign / finding	Likely shock type	Immediate action
Prolonged CRT + narrow pulse pressure (PP)	Cold shock	Start epinephrine infusion
Flash CRT + wide PP	Warm shock	Start norepinephrine infusion
Lactate >4 mmol/l post-bolus	Any	Start vasoactives; consider adrenal insufficiency
Hypotension (late sign)	Any	Immediate fluid + vasoactive support

Advanced Rescue Strategies

When first-line therapies fail, advanced strategies are essential.

Second-Line Agents

• Vasopressin/Terlipressin: Acts via V1a receptors to increase SVR. Used in catecholamine-resistant vasodilatory shock. It improves the mean arterial pressure (MAP) and organ function but no proven mortality benefit. Risk of excessive vasoconstriction and ischemia.^38,39

• Milrinone: A phosphodiesterase inhibitor that increases myocardial contractility and lustropy (relaxation). First-line for shock with myocardial dysfunction. Avoid loading dose due to vasoplegia risk.^40,41

• Methylene Blue: Inhibits nitric oxide-mediated vasodilation. Effective in catecholamine-refractory shock with normal ventricular function (per POCUS). Side effects are mild and transient (blue-green discoloration). ⁴²

Corticosteroids

The role of hydrocortisone in catecholamine-resistant shock remains debated. It may improve cardiovascular function by enhancing catecholamine sensitivity. SSC guidelines recommend it for suspected/confirmed adrenal insufficiency. ⁴³ Evidence on mortality is inconclusive; a Cochrane review suggested reduced short-term mortality but highlighted uncertainty about long-term benefits. Risks include hyperglycemia, hypernatremia, and superinfection.^44,45 The cosyntropin stimulation test is of limited utility as a high response may reflect illness severity rather than true insufficiency. Evidence on mortality benefit from corticosteroids remains inconclusive. A Cochrane review suggested reduced short-term mortality but highlighted uncertainty about long-term benefits, along with risks of hyperglycemia, hypernatremia, and superinfection. ⁴⁶

Point-of-Care Ultrasound (POCUS)

POCUS is a transformative, non-invasive tool for managing refractory shock.

• Shock differentiation: Protocols like Rapid Ultrasound in Shock (RUSH) and Pediatric RUSH (p-RUSH) enable rapid hemodynamic phenotyping, even in resource-limited settings. ⁴⁷

• Guided management: Allows dynamic assessment of cardiac filling and contractility, guiding fluid responsiveness and preventing overload. ⁴⁸

• Procedural safety: Enhances the safety and success of bedside procedures. ⁴⁷ Integrating POCUS into ED workflows improves diagnostic accuracy, streamlines management, and facilitates timely critical care delivery. (See Figure 2)

Figure 2.

Pediatric shock rescue algorithm incorporating POCUS assessment and stepwise management.

Refractory Shock in Low-Resource Settings

Mortality from pediatric refractory shock in LMIC EDs ranges from 40% to 60%, exacerbated by systemic barriers. ⁴⁹

• Epidemiology: The WHO defines shock by the triad of weak tachycardic pulse, cold extremities, and CRT >3 seconds. While this identifies a small proportion of cases (0.1%-0.14% of admissions), they carry extreme mortality rates (41.5%-100%).^50,51 The FEAST trial fundamentally changed practice, proving fluid boluses are harmful in settings lacking ICU support. ²⁷

• Systemic barriers: Challenges include limited diagnostics (no arterial blood gas [ABG], lactate, POCUS), unreliable drug supply, lack of infusion pumps (requiring error-prone manual micro infusions), scarce mechanical ventilation, and no renal replacement therapy. Human resource deficits (limited PALS training) and delayed transfers without critical care support further hinder outcomes.^52,53

• Contextual adaptations: Successful strategies include:

• ○ Vascular access: Use of standard 16/18 G needles if pediatric IO needles are unavailable.

• ○ Drugs: Manual micro infusion sets, early antibiotics, stress-dose hydrocortisone.

• ○ Monitoring: Reliance on clinical endpoints: HR normalization, CRT <2 seconds, warm extremities, improved mental status, urine output >1 ml/kg/h^54,55 (See Table 5).

Table 5.

Resource-Adapted Management: HIC Versus LMIC Reality.

Aspect	HIC standard	LMIC-adapted approach	Key barriers
Fluids	Aggressive boluses + advanced monitoring	Conservative boluses + clinical reassessment	Limited monitoring, FEAST evidence
Vasoactive delivery	Infusion pumps, broad availability	Manual micro infusion, limited supply	Lack of pumps, drug shortages
Monitoring	Continuous blood pressure, ABG, lactate, POCUS	Basic vitals, CRT, clinical endpoints	Scarce equipment, observer variability

Future Directions: Simulation, Bundles, and Tele-ICU

Improving outcomes in LMICs requires innovative, context-appropriate solutions.

• Simulation-Based Training (SBT): SBT is highly effective for building competency in high-stakes, low-frequency scenarios. Low-fidelity, locally adaptable simulations can practice clinical skills (eg, CRT assessment), decision-making without advanced monitoring, and therapeutic challenges (eg, manual drug infusion). In Kenya, an SBT program improved correct fluid dose calculation from 52% to 91%.^33,56

• Bundled care tools: Simplified, pragmatic bundles standardize care and reduce practice variation. A model LMIC shock bundle prioritizes actions from 0 to 60 minutes: early recognition, vascular access, cautious fluids, oxygen, early antibiotics, and hypoglycemia screening/treatment^57,58 (See Table 6).

• Tele-ICU integration: Tele-ICU programs connect remote experts with frontline clinicians, providing real-time guidance on vasopressor titration, fluid management, and decision-making. An initiative in India reduced transfer mortality in septic shock by nearly 50%. Despite barriers like internet connectivity, tele-ICU offers a platform for mentorship and capacity building, improving stabilization and outcomes.^59,60

Table 6.

LMIC Pediatric Shock Bundle (0-60 minutes).

Time (min)	Action	Description
0	Early recognition	Assess perfusion, mental status, CRT
0-10	Vascular access	Establish IV/IO line
10-30	Fluid resuscitation	Administer 10 to 20 ml/kg isotonic crystalloid cautiously
0-60	Antibiotics	Administer broad-spectrum antibiotics early
0-60	Hypoglycemia screen	Check glucose and treat promptly if low

Similar challenges exist in rural and remote areas of high-income countries. In the United States, lower emergency department pediatric readiness has been associated with increased mortality in critically ill children. Telemedicine programs in the Intermountain West have successfully bridged gaps in pediatric expertise, providing a model applicable to both domestic rural settings and international resource-limited environments ⁶¹

Conclusion

Early recognition and precise, phenotype-specific management of pediatric shock are central to improving survival. Advances such as POCUS, tailored fluid strategies, and second-line agents enhance timely decision-making in advanced care settings. In resource-limited environments, the paradigm has shifted toward conservative fluid resuscitation, supported by context-adapted protocols, SBT, and innovative telemedicine solutions. Future efforts must focus on harmonizing evidence-based protocols across diverse health systems and expanding access to these innovative tools to strengthen emergency care delivery and reduce global disparities in pediatric shock outcomes.